首页> 外文期刊>Frontiers in Cell and Developmental Biology >Global Gene Expression Profiling Reveals Isorhamnetin Induces Hepatic-Lineage Specific Differentiation in Human Amniotic Epithelial Cells
【24h】

Global Gene Expression Profiling Reveals Isorhamnetin Induces Hepatic-Lineage Specific Differentiation in Human Amniotic Epithelial Cells

机译:全局基因表达谱揭示了Isorhamnetin在人羊膜上皮细胞中诱导肝谱系特异性分化

获取原文
           

摘要

Human amnion epithelial cells (hAECs), derived from discarded term placenta, is anticipated as a new stem cell resource because of their advantages over embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), such as no risk of tumorigenicity and minimal ethical issue. hAECs have been reported to differentiate into hepatocyte-like cells (HLCs) with variable functionalities suitable for cell-based therapy of end-stage liver diseases, drug screening, and drug toxicity tests. On the other hand, a new research stream has been evolving to use natural compounds as stimulants of stem cell differentiation because of their high availability and minimum side effects. Isorhamnetin is a naturally occurring flavonoid commonly found in fruits and vegetables and has been reported to improve hepatic fibrosis and steatosis. In this present study, we have screened the differentiation potential of isorhamnetin in hAECs. The cells were grown on 3D cell culture and were treated with 20 uM of synthesized isorhamnetin for ten days without adding any additional growth factors. DNA microarray global gene expression analysis was conducted for differentially expressed genes between isorhamnetin-treated and untreated control cells, gene expression validation was carried out using RT-qPCR method, and finally, several hepatic functions were assessed. Microarray analysis showed that isorhamnetin could activate essential biological processes, molecular functions, and signaling pathways for hepatic differentiation. Hepatic progenitor markers, EPCAM and DLK1, were upregulated in the isorhamnetin-treated hAECs. AFP was downregulated, while ALB was upregulated on Day 10. Furthermore, isorhamnetin-treated cells could show inducible CYP enzyme mRNA levels, ICG uptake and release, glycogen storage activity, and urea secretion. Additionally, isorhamnetin-treated cells did not show any trace of transdifferentiation evident by significant downregulation of several colon- and cholangiocyte-specific markers. However, longer treatment with isorhamnetin did not promote hepatic maturation. Altogether, our findings indicate that isorhamnetin has a promising effect on hAEC differentiation into hepatocyte-like cells.
机译:由于其优于胚胎干细胞(ESC)和诱导多能干细胞(IPSC),因此预期从废弃术语胎盘的人嗜氨型上皮细胞(HAECs)被预期作为新的干细胞资源,例如诱导多能干细胞(IPSC),例如没有肿瘤的风险和最小的风险道德问题。据报道,HAECS分化为肝细胞样细胞(HLC),其可变官能团,适用于终级肝病,药物筛选和药物毒性试验。另一方面,由于其高可用性和最小副作用,新的研究流已经不断使用天然化合物作为干细胞分化的兴奋剂。 Isorhamnetin是一种天然存在的黄酮常见于水果和蔬菜中,并据报道,提高肝纤维化和脂肪变性。在本研究中,我们筛选了在HAECS中的Isorhamnetin的分化潜力。细胞在3D细胞培养物上生长,并用20μm合成的Isorhamnetin治疗10天,而不增加任何额外的生长因子。对DNA微阵列全局基因表达分析进行Isorhamnetin处理和未处理对照细胞之间的差异表达基因,使用RT-QPCR方法进行基因表达验证,最后,评估几种肝功能。微阵列分析表明,Isorhamnetin可以激活必需的生物过程,分子函数和用于肝脏分化的信号通路。肝祖祖标记,EPCAM和DLK1在Isorhamnetin治疗的HAEC中上调。下调AFP,而ALB在第10天上调。此外,Isorhamnetin治疗细胞可以显示诱导的CYP酶mRNA水平,ICG吸收和释放,糖原储存活性和尿素分泌。另外,Isorhamnetin处理的细胞未显示出几种结肠和胆管细胞特异性标记物的显着下调的任何痕量转移细胞。然而,与Isorhamnetin的更长的治疗没有促进肝脏成熟。我们的研究结果表明,ISORHamnetin对HAEC分化的有希望的效果,进入肝细胞样细胞。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号